From families to chromosomes: Genetic linkage and association studies for finding cancer-predisposition genes

Genetic Predisposition to Cancer, Second Edition

Volumn , Issue , 2003, Pages 21-40

  Easton, Douglas F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40049103042     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (85)

1. Dausset J, Colombani J, Hors J. Major histocompatibility complex and cancer. Cancer Surveys 1982; 1:120–147.
2. Simons MJ, Wee GB, Chan SH, et al. Probable identification of an HLA second locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet 1975;i:142–143.
3. Hoskins LC, Loux HA, Britten A, Zamcheck N. Distribution of ABO blood groups in patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated with blood group A. N Engl J Med 1965; 273:633–637.
4. Botstein D, White R, Skolnick MH, Davis R. Construction of a genetic linkage map in map using restriction fragment length polymorphisms. Am J Hum Genet 1980; 32:314–331.
5. Bodmer WF, Bailey CJ, Bodmer J, et al. Localisation of the gene for familial adenomatous polyposis on chromosome. Nature 1987; 328:614–616.
6. Mathew CGP, Chin KS, Easton DF, et al. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome. Nature 1987; 328:527–528.
7. Simpson NE, Kidd KK, Goodfellow PJ, et al. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 1987; 328:528–530.
8. Peltomaki L, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993; 260:810–812.
9. Lindblom A, Tannergard P, Werelius B, Nordenskjord M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 1993; 5:279.
10. Cannon-Albright LA, Goldgar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13–p22. Science 1992; 258:1148–1152.
11. Hall JM, Lee MK, Morrow J, et al. Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science 1990; 250:1684–1689.
12. Wooster R, Neuhausen S, Mangion J, et al. Localization of a breast cancer susceptibility gene to chromosome 13q12–q13. Science 1994; 265:2088–2090.
13. Easton DF, Bishop DT, Ford D, Crockford GP. Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52:678–701.
14. Narod SA, Ford D, Devilee P, et al. An evaluation of genetic heterogeneity in 145 breast–ovarian cancer families. Am J Hum Genet 1995; 56:254–264.
15. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62:334–345.
16. Ott J. Analysis of human genetic linkage, 3rd edn. Baltimore: Johns Hopkins University Press, 1999.
17. Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet 1955; 7:277–318.
18. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265:2037–2048.
19. Sawcer S, Jones HB, Judge D, et al. Empirical genomewide significance levels established by whole genome simulations. Genet Epidemiol 1997; 14:223–229.
20. Skolnick MH, Thompson EA, Bishop DT, Cannon LA. Possible linkage of a breast cancer susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation. Genet Epidemiol 1984; 1:363–373.
21. Weeks DE, Ott J, Lathrop GM. SLINK: a general simulation program for linkage analysis. Am J Hum Genet 1990; 47:A204.
22. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984; 81:3443–3446.
23. Cottingham RW Jr, Idury RM, Schäffer AA. Faster sequential genetic linkage computations. Am J Hum Genet 1993; 53:252–263.
24. O’Connell JR, Weeks DE. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance. Nature Genet 1995; 11:402–408.
25. Cohen BB, Porter DE, Wallace MR, et al. Linkage of a major breast cancer gene to chromosome 17q12–21: results from 15 Edinburgh families. Am J Hum Genet 1993; 52:723–729.
26. Lander ES, Green P. Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci USA 1987; 84: 2363–2367.
27. Kruglyak L, Daly MJ, Reeve-Daly MP, et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347–1363.
28. Kong A, Cox N, Frigge M, Irwin M. Sequential imputation and multipoint linkage analysis. Genet Epidemiol 1993; 10:483–488.
29. Guo SW, Thompson EA. A monte carlo method for combined segregation and linkage analysis. Am J Hum Genet 1992; 51:1111–1126.
30. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131:961–972.
31. Weeks DE, Sobel E, O’Connell JR, Lange K. Computer programs for multilocus haplotyping of general pedigrees. Am J Hum Genet 1995; 56:1506–1507.
32. Hastbacka J, de la Chapelle A, Mahtani MM, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter–positional cloning by fine structure linkage disequilibrium mapping. Cell 1994; 78:1073–1087.
33. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98:503–517.
34. Jeffreys AJ, Wilson V, Thein SL. Hypervariable minisatellite regions in human DNA. Nature 1985; 314:67–73.
35. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989; 44:388–396.
36. Eeles RA, Stamps AC. Polymerase chain reaction (PCR): the technique and its applications. Austin TX: RG Landes, 1993.
37. Kruglyak L. The use of a genetic map of biallelic markers in linkage analysis. Nature Genet 1997; 17:121–124.
38. Smith CAB. Homogeneity test for linkage data. Proc Second Int Congr Hum Genet 1961; 1:212–213.
39. Nyström-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 1994; 55:659–665.
40. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75:1215–1225.
41. Lander ES, Botstein D. Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms. Proc Natl Acad Sci USA 1986; 83:7353–7357.
42. Chiano MN, Yates JR. Linkage detection under heterogeneity and the mixture problem. Ann Hum Genet 1995; 59:83–95.
43. Holmans P. Asymptotic properties of affected-sib-pair linkage analysis. Am J Hum Genet 1993; 52:362–374.
44. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990; 46:226–241.
45. Bishop DT, Williamson JA. The power of identity-by-state methods for linkage analysis. Am J Hum Genet 1990; 46:254–265.
46. Weeks DE, Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988; 42: 315–326.
47. Clerget-Darpoux F, Bonaiti-Pellie C, Hochez J. Effects of misspecifying genetic parameters in LOD score analysis. Biometrics 1985; 42:393–399.
48. Risch N, Giuffra L. Model misspecification and multipoint linkage analysis. Hum Hered 1992; 42:77–92.
49. Green P. Genetic linkage and complex diseases: a comment. Genet Epidemiol 1990; 7:25–27.
50. MacClean CJ, Bishop DT, Sherman SL, Diehl SR. Distribution of LOD scores under uncertain mode of inheritance. Am J Hum Genet 1993; 52:354–361.
51. Ploughman LM, Boehnke M. Estimating the power of a proposed linkage study for a complex genetic trait. Am J Hum Genet 1989; 44: 543–551.
52. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. A systematic population based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600–1608.
53. Goldgar DE, Easton DF. Optimal strategies for mapping complex disease loci in the presence of genetic heterogeneity. Am J Hum Genet 1997; 60:1222–1232.
54. Risch N. Segregation analysis incorporating linkage markers. I. Single-locus models with an application to type 1 diabetes. Am J Hum Genet 1984; 36:363–386.
55. Greenberg DA. Inferring mode of inheritance by comparison of LOD scores. Am J Med Genet 1989; 35:480–486.
56. Burt RW, Cannon-Albright LA, Bishop DT, et al. Familial factors in sporadic adenomas and colorectal cancer. Problems Gen Surg 1993; 10:688–694.
57. Green A, Swerdlow AJ. Epidemiology of melanocytic naevi. Epidemiol Rev 1989; 11: 204–221.
58. Day N, Warren R. Mammographic screening and mammographic patterns. Breast Cancer Res 2000; 2:247–251.
59. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002; 347: 886–894.
60. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94:606–616.
61. Scott D, Jones LA, Elyan SAG, et al. Identification of A-T heterozygotes. In: Gatti RA, Painter RB (eds) Ataxiatelangiectasia. Berlin: Springer-Verlag, 1992;101–116.
62. Goldgar DE, Cannon-Albright LA, Meyer LJ, et al. Inheritance of nevus number and size in melanoma/DNS kindreds. Cytogenet Cell Genet 1992; 59:200–202.
63. Risch N, Sherman S. Genetic Analysis Workshop 7: summary of the melanoma workshop. Cytogenet Cell Genet 1992; 59:148–158.
64. Page GP, Amos CI, Boerwinkle E. The quantitative LOD score: test statistic and sample size for exclusion and linkage of quantitative traits in human sibships. Am J Hum Genet 1998; 62:962–968.
65. Healey CS, Dunning AM, Teare MD, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nature Genet 2000; 26:362–364.
66. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997; 53:1253–1261.
67. Breslow NE, Day NE. Statistical methods in cancer research Vol I. The design and analysis of case-control studies. IARC scientific publication no. Lyon: IARC, 1980.
68. Easton DF, Peto J, Babiker A. Floating absolute risks–an alternative to choosing an arbitrary reference group in survival analysis and case-control studies. Statistics Med 1991;10:1025–1035.
69. Dunning AM, Healey CS, Pharoah PDP, et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8:843–854.
70. Risch N, Merikangas KR. The future of genetic studies of complex human diseases. Science 1996; 273:1516–1517.
71. Weir BS. Genetic data analysis: methods for discrete population genetic data. Sunderland, MA: Sinauer, 1990.
72. Gabriel SB, Schaffner SF, Nguyan H, et al. The structure of haplotypes in the human genome. Science 2002; 296:2225–2229.
73. Spielman RS, McGinnis RE, Ewens WJ. Transmission disequilibrium test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516.
74. Self S, Longton G, Kopecky K, Liang K-Y. On estimating HLA/disease association ith application to a study of aplastic anaemia. Biometrics 1991; 47:53–61.
75. Goode EL, Dunning AM, Healey CS, et al. Assessment of population stratification in a large population-based cohort. Genet Epidemiol 2002; 21:A126.
76. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55:997–1004.
77. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999; 65: 220–228.
78. Reich DE, Goldstein DB. Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol 2001; 20: 4–16.
79. Antoniou A, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003; Nov 25(3):190–202.
80. Stephens JC, Briscoe D, O’Brien SJ. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. Am J Hum Genet 1994; 55:603–624.
81. McKeigue PM. Mapping genes underlying ethnic differences in disease risk by linkage disequilibrium in recently admixed populations. Am J Hum Genet 1997; 60: 188–196.
82. Kainu T, Juo SH, Desper R, et al. Somatic deletions in hereditary breast cancers implicate 13q21 as a putatitve novel breast cancer susceptibility locus. Proc Natl Acad Sci USA 2000; 97:9603–9608.
83. Thompson D, Szabo CI, Mangion J, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA 2002; 99:827–831.
84. Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000; 67:1367–1375.
85. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69:124–137.